Prelude Capital Management’s HUTCHMED HCM Stock Holding History

Prelude Capital Management’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,134	Closed	-$179K	–	1304
2022 Q4	$179K	Buy	+12,134	New	+$133K	0.01%	994

Other funds holding HCM

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prelude Capital Management's HCM Position: Q1 2023 in Review

Prelude Capital Management sold out of HUTCHMED (HCM) in Q1 2023, closing a stake of 12,134 shares — an estimated $179K sold.

Prelude Capital Management first reported a position in HCM in Q4 2022 and held it in 1 quarter. The position peaked at $179K in Q4 2022. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2023.

Prelude Capital Management reported no remaining HUTCHMED position as of Q1 2023 after selling out during the quarter.
Prelude Capital Management sold 12,134 HUTCHMED shares in Q1 2023, an estimated $179K.
Prelude Capital Management first reported a position in HUTCHMED in Q4 2022 and held it in 1 quarter.
Prelude Capital Management's HUTCHMED position peaked at $179K in Q4 2022.
71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.